Effect of phenylurea hydroxamic acids on histone deacetylase and VEGFR-2.
Bioorg Med Chem
; 50: 116454, 2021 11 15.
Article
em En
| MEDLINE
| ID: mdl-34634618
ABSTRACT
A series of phenylurea hydroxamic acids incorporating pharmacophores of inhibitors of HDAC inhibitors and VEGFR-2 has been designed. Most of the compounds show antiproliferative activity comparable to that of Vorinostat and Sorafenib, and better EPC inhibitory activity. Enzymatic assays and Western blotting results indicated that compound 14 not only inhibits HDAC but also has slight VEGFR-2 inhibitory activity. A docking study revealed that the polar hydroxamic acid retains the interaction with HDAC through a zinc ion and also interacts with some residues of the active site of VEGFR-2. Despite 14 displaying a weaker VEGFR-2 activity, a possible route to develop potent HDAC/VEGFR-2 inhibitors is suggested.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Compostos de Fenilureia
/
Inibidores de Proteínas Quinases
/
Inibidores de Histona Desacetilases
/
Ácidos Hidroxâmicos
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article